Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/29/3228229/0/en/Study-Results-of-Novel-TYK2-Inhibitor-Soficitinib-in-Patients-with-AD-Published-by-JAMA-Dermatology.html

GLOBENEWSWIRE
29 Jan 2026

https://www.prnewswire.com/news-releases/nature--two-phase-3-clinical-results-of-mazdutide-glp-1gcg-dual-receptor-agonist-in-chinese-adults-with-type-2-diabetes-have-been-back-to-back-published-in-nature-302644606.html

PR NEWSWIRE
17 Dec 2025